Baillie Gifford & Co. cut its stake in Cardlytics, Inc. (NASDAQ:CDLX – Free Report) by 91.1% in the fourth quarter, Holdings Channel reports. The institutional investor owned 50,413 shares of the company’s stock after selling 516,983 shares during the period. Baillie Gifford & Co.’s holdings in Cardlytics were worth $187,000 at the end of the most recent quarter.
A number of other institutional investors also recently bought and sold shares of CDLX. RBF Capital LLC lifted its position in Cardlytics by 311.9% in the third quarter. RBF Capital LLC now owns 488,128 shares of the company’s stock worth $1,562,000 after buying an additional 369,620 shares during the last quarter. GSA Capital Partners LLP lifted its position in Cardlytics by 1,273.2% in the third quarter. GSA Capital Partners LLP now owns 382,315 shares of the company’s stock worth $1,223,000 after buying an additional 354,474 shares during the last quarter. Jacobs Levy Equity Management Inc. lifted its position in shares of Cardlytics by 56.0% during the third quarter. Jacobs Levy Equity Management Inc. now owns 317,644 shares of the company’s stock worth $1,016,000 after purchasing an additional 113,966 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of Cardlytics by 7.5% during the third quarter. Geode Capital Management LLC now owns 1,053,178 shares of the company’s stock worth $3,371,000 after purchasing an additional 73,484 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd bought a new stake in shares of Cardlytics during the third quarter worth $153,000. 68.10% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
Several analysts have recently weighed in on the company. Craig Hallum upgraded Cardlytics from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, November 6th. Needham & Company LLC reiterated a “hold” rating on shares of Cardlytics in a research report on Friday, January 17th. One analyst has rated the stock with a sell rating, five have given a hold rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $6.92.
Insider Activity
In other news, CFO Alexis Desieno sold 8,854 shares of the company’s stock in a transaction dated Friday, January 3rd. The shares were sold at an average price of $3.67, for a total transaction of $32,494.18. Following the transaction, the chief financial officer now owns 121,976 shares in the company, valued at $447,651.92. This represents a 6.77 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Amit Gupta sold 15,160 shares of the company’s stock in a transaction dated Friday, January 24th. The shares were sold at an average price of $3.92, for a total transaction of $59,427.20. Following the transaction, the chief executive officer now owns 215,494 shares in the company, valued at approximately $844,736.48. This trade represents a 6.57 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 64,597 shares of company stock worth $232,550 over the last 90 days. 4.40% of the stock is currently owned by corporate insiders.
Cardlytics Stock Performance
Shares of Cardlytics stock opened at $3.37 on Wednesday. Cardlytics, Inc. has a 12 month low of $2.76 and a 12 month high of $20.52. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 2.40. The firm has a market cap of $171.26 million, a P/E ratio of -0.55 and a beta of 1.54. The stock’s fifty day moving average price is $3.47 and its 200-day moving average price is $3.73.
Cardlytics Company Profile
Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.
Featured Articles
- Five stocks we like better than Cardlytics
- What Do S&P 500 Stocks Tell Investors About the Market?
- Hims & Hers Earnings Could Be a Game Changer—What to Do Now
- How to Calculate Stock Profit
- DeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI Stocks
- How to invest in marijuana stocks in 7 steps
- Mortgage Market Bottom? Why Rocket Companies Could Be a Buy
Want to see what other hedge funds are holding CDLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardlytics, Inc. (NASDAQ:CDLX – Free Report).
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.